Compare Morgan Stanley (MS) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Morgan Stanley vs Oscar Health Inc — how do they compare? Morgan Stanley trades at $218.09 (market cap $338.09B), while Oscar Health Inc trades at $29.57 (market cap $8.63B). The key difference: Morgan Stanley is far larger — about 39.2× Oscar Health Inc's market cap, and Morgan Stanley pays a 2.14% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals.
| MS | OSCR | |
|---|---|---|
Market Cap | $338.09B | $8.63B |
Sector | Financials | Health |
52-Week High | $228.42 | $32.18 |
52-Week Low | $144.04 | $10.85 |
Dividend Yield | 2.14% | — |
Enterprise Value | — | $4.99B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Morgan Stanley (MS) trades at $215.27, down 0.46% on the day, with a neutral technical signal. The stock shows strong fundamentals, with revenue growing from $50.2B in 2022 to $66.0B in 2025 and net income margin expanding to 27.59%. Recent earnings beats and the selection to lead the Anthropic IPO highlight operational strength. The consensus analyst price target is $239.58, implying potential upside.
The outlook is positive, supported by earnings momentum and strategic initiatives like AI integration in wealth management. Key risks include volatile cash flows from operations and high leverage, with debt-to-asset ratio rising to 26.1 in 2025. Analyst sentiment is bullish, with 55.77% recommending Buy.
Oscar Health (OSCR) trades at $29.11, up 5.2% with strong recent earnings momentum, beating estimates in Q1 and Q2 2026. The stock shows bearish technical signals but benefits from record profitability and raised 2026 guidance. Revenue surged 70% to $4.9 billion in H1 2026, with net income turning positive at $551 million versus a 2025 loss. Valuation remains attractive with P/S of 0.53, suggesting potential undervaluation versus sector peers.
Outlook is positive given membership growth and cost discipline, but risks include medical cost volatility and competitive pressures. Analyst consensus price target of $32.50 implies 12% upside, though technical resistance near $30 may limit near-term gains. Execution on guidance and sustained margin expansion are key catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Morgan Stanley
Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments. The company had about $5 trillion of client assets as well as over 70,000 employees at the end of 2021. Approximately 50% of the company's net revenue is from its institutional securities business, with the remainder coming from wealth and investment management. The company derives about 30% of its total revenue outside the Americas.
Read more on MS →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
